Table of Contents

company-logo

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

NovaBay Pharmaceuticals Dividend Announcement

• NovaBay Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on NovaBay Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

NovaBay Pharmaceuticals Dividend History

NovaBay Pharmaceuticals Dividend Yield

NovaBay Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NovaBay Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

NovaBay Pharmaceuticals Financial Ratios

P/E ratio-0.23
PEG ratio0.02
P/B ratio2.15
ROE-1030.19%
Payout ratio0.00%
Current ratio1.15
Quick ratio0.91
Cash Ratio0.39

NovaBay Pharmaceuticals Dividend FAQ

Does NovaBay Pharmaceuticals stock pay dividends?
NovaBay Pharmaceuticals does not currently pay dividends to its shareholders.
Has NovaBay Pharmaceuticals ever paid a dividend?
No, NovaBay Pharmaceuticals has no a history of paying dividends to its shareholders. NovaBay Pharmaceuticals is not known for its dividend payments.
Why doesn't NovaBay Pharmaceuticals pay dividends?
There are several potential reasons why NovaBay Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NovaBay Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NovaBay Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NovaBay Pharmaceuticals a dividend aristocrat?
NovaBay Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NovaBay Pharmaceuticals a dividend king?
NovaBay Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NovaBay Pharmaceuticals a dividend stock?
No, NovaBay Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NovaBay Pharmaceuticals stocks?
To buy NovaBay Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NovaBay Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.